Tenet Healthcare Corporation (NYSE:THC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Tenet Healthcare Corporation (NYSE:THC) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are presently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $231.8125.

A number of brokerages have recently weighed in on THC. Bank of America boosted their price target on Tenet Healthcare from $205.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Zacks Research downgraded shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Cantor Fitzgerald increased their price objective on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Wells Fargo & Company lifted their target price on Tenet Healthcare from $238.00 to $252.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Finally, Truist Financial reiterated a “buy” rating and set a $240.00 price target (up from $225.00) on shares of Tenet Healthcare in a research report on Monday, November 3rd.

Tenet Healthcare Trading Up 0.3%

THC opened at $199.39 on Friday. The stock has a market capitalization of $17.52 billion, a PE ratio of 13.67, a P/E/G ratio of 0.85 and a beta of 1.41. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.64. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $222.82. The firm’s fifty day moving average price is $202.68 and its 200 day moving average price is $188.69.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The business had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, research analysts expect that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Activity

In other news, Director Richard W. Fisher sold 2,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total transaction of $521,075.00. Following the sale, the director owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider R. Scott Ramsey sold 13,322 shares of the stock in a transaction that occurred on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total value of $2,732,475.42. The SEC filing for this sale provides additional information. Insiders sold 45,500 shares of company stock worth $9,247,071 in the last 90 days. 0.81% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tenet Healthcare

Large investors have recently bought and sold shares of the stock. Triumph Capital Management acquired a new stake in Tenet Healthcare during the 3rd quarter worth about $25,000. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare during the 3rd quarter worth approximately $32,000. Westside Investment Management Inc. lifted its holdings in shares of Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares in the last quarter. Chung Wu Investment Group LLC acquired a new stake in shares of Tenet Healthcare in the second quarter worth $35,000. Finally, Trust Co. of Vermont acquired a new position in Tenet Healthcare during the third quarter valued at $41,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.